much more at 4:00. the air. police on the scene of a shopping mall shooting in boyid. the shooting inside the mall. reports of several people shot. news on their conditions. police rushing to the scene. evacuating stores. what authorities are saying about the gunman. tracking dangerous storms with flooding rain and winds, a possible nor easter and heavy rain from washington, d.c. to new york to boston and new snow and wind alerts from california to colorado, just 24 hours after the most powerful storm ever recorded off the pacific northwest. rob marciano timing it all out. the fda panel on the eve of its decision on the pfizer
and like pfizer, moderna says its vaccine was safe in the younger group with mild side effects like headache, sore arm, fever and fatigue. pediatricians who care for these kids want to find a solution. it s a miracle we potentially have one. reporter: 28 million children could be eligible for a pfizer shot as early as thursday, november 4th, after a green light from the fda and cdc. the pfizer vaccine was found to be 91% effective in 5 to 11 year olds. pediatrician amanda dropic enrolled all four of her children in the pfizer trial. if it s something i can prevent with a vaccine that is both safe and effective, that s my job to protect my kids and other people s kids to the best of my ability. reporter: 11-year-old eli and 9-year-old lila say they ll encourage their friends to get vaccinated. they should definitely get vaccinated. it really doesn t hurt and it s definitely worth it even if you
rob, thanks so much. next, a new shot of hope for children. moderna announcing the results of their latest study finding it was safe and event if in children 8-11 years old. it s a half dose of the adult vaccine. tomorrow an fda advisory panel will review pfizer s vaccine for children 5-11 years old. it could clear the fda and cdc by the first week of november. when it does, the biden administration says there will be millions of doses ready to go. here s abc s erielle reshef. reporter: just a day before an fda panel is set to review and rule on pfizer s vaccine for 5 to 11-year-olds, promising news on moderna s vaccine in younger children. the company reporting a strong immune response in kids 6 to 11. at just half the adult dose, two shots given 28 days apart produced one and a half times the antibodies seen in young adults.
get a few side effects. reporter: just as soon as the vaccine is authorized for 5 to 11 year olds, the white house says millions of doses will ship out so they are ready at doctor s offices, children s hospitals, pharmacies and clinics. for a lot of parents they don t get time off work. if you want an appointment that works for you, it s not too soon to call up and get in line. erielle, certainly all eyes on tomorrow s fda panel meeting on the pfizer vaccine. walk us through the next steps. reporter: well, that fda panel is expected to make its decision by the end of tomorrow. if the fda gives the green light, then the cdc could sign off by next wednesday which means we could see some of those younger children get their shots in arms by the end of next week. to the relief of many. erielle, thank you. next, new details about the fatal shooting on the set of the movie rust.